alaproclate has been researched along with Dementia in 2 studies
alaproclate: specific 5-hydroxytryptamine uptake inhibitors; RN given refers to (DL)-isomer
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind parallel comparison of alaproclate and placebo was carried out in patients suffering from senile dementia of primary degenerative type, or multiinfarction dementia." | 9.05 | A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia. ( Dehlin, O; Hedenrud, B; Jansson, P; Nörgård, J, 1985) |
| "Alaproclate, a specific inhibitor of neuronal serotonin re-uptake, was given to 12 patients with dementia of Alzheimer type." | 7.66 | Alaproclate: a pharmacokinetic and biochemical study in patients with dementia of Alzheimer type. ( Bergman, I; Bråne, G; Gottfries, CG; Jostell, KG; Karlsson, I; Svennerholm, L, 1983) |
| "A double-blind parallel comparison of alaproclate and placebo was carried out in patients suffering from senile dementia of primary degenerative type, or multiinfarction dementia." | 5.05 | A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia. ( Dehlin, O; Hedenrud, B; Jansson, P; Nörgård, J, 1985) |
| "Alaproclate, a specific inhibitor of neuronal serotonin re-uptake, was given to 12 patients with dementia of Alzheimer type." | 3.66 | Alaproclate: a pharmacokinetic and biochemical study in patients with dementia of Alzheimer type. ( Bergman, I; Bråne, G; Gottfries, CG; Jostell, KG; Karlsson, I; Svennerholm, L, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergman, I | 1 |
| Bråne, G | 1 |
| Gottfries, CG | 1 |
| Jostell, KG | 1 |
| Karlsson, I | 1 |
| Svennerholm, L | 1 |
| Dehlin, O | 1 |
| Hedenrud, B | 1 |
| Jansson, P | 1 |
| Nörgård, J | 1 |
1 trial available for alaproclate and Dementia
| Article | Year |
|---|---|
A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia.
Topics: Aged; Alanine; Clinical Trials as Topic; Dementia; Double-Blind Method; Female; Humans; Intelligence | 1985 |
1 other study available for alaproclate and Dementia
| Article | Year |
|---|---|
Alaproclate: a pharmacokinetic and biochemical study in patients with dementia of Alzheimer type.
Topics: Aged; Alanine; Alzheimer Disease; Dementia; Female; Humans; Kinetics; Male; Serotonin | 1983 |